Cumulus Oncology

Ian Waddell, chief scientific officer, and Clare Doris, chief operating officer, of Cumulus. Picture: Stewart Attwood

Edinburgh cancer discovery accelerator Cumulus hires chief scientific officer

Dr Diane Seimetz, Clare Doris, Clare Wareing, Nicola Broughton and Dr Sally Waterman of Cumulus. Picture: Stewart Attwood

Edinburgh cancer discovery accelerator Cumulus gets £4.1m funding injection

From left: Cumulus boss Clare Wareing and Nicola Broughton, who has been named chief business officer. Picture: Stewart Attwood.

Edinburgh-based life sciences firm Cumulus Oncology unveils senior appointments

Clare Wareing and Nicola Broughton of Cumulus Oncology. Picture: Stewart Attwood

Edinburgh drug discovery accelerator targets fresh investment as director named

Clare Doris and Clare Wareing of Cumulus Oncology, which is based in Edinburgh. Picture: Stewart Attwood

Cumulus appoints Edinburgh Uni neuroscience graduate as chief operating officer

L to R: Clare Wareing and Alan Wise (both Cumulus Oncology) and Mark Beaumont and Andrew McNeill (both Eos Advisory). Picture: Stewart Attwood

Edinburgh cancer drug accelerator seals 'strategic partnership' with German peer

Alan Wise and Clare Wareing of Edinburgh-based Cumulus Oncology. Picture: Stewart Attwood

Edinburgh-based oncology drug discovery accelerator eyes global growth

The life sciences boss wants to remain part of efforts to turn scientific discoveries into meaningful new treatment options for cancer patients. Picture: Stewart Attwood.

The Big Interview: Cumulus Oncology founder and CEO Clare Wareing

Left to right are Clare Wareing and Alan Wise of Cumulus Oncology and Mark Beaumont and Andrew McNeill of Eos Advisory. Picture: Stewart Attwood

Biotech boost as Edinburgh cancer drugs accelerator secures major funding